This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Evotec Nominates Wolfgang Hofmann to Board
Business board nomination

Evotec Nominates Wolfgang Hofmann to Board

Analysis based on 7 articles · First reported Apr 29, 2026 · Last updated Apr 29, 2026

Sentiment
10
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The nomination of Wolfgang Hofmann and the cooperation agreement with MAK Capital Fund are expected to strengthen Evotec's governance and oversight, potentially leading to increased shareholder confidence and long-term value creation. This could positively influence Evotec's stock performance.

biotechnology pharmaceuticals
Event Summary

Evotec announced the nomination of Dr. Wolfgang Hofmann for election as an independent member of its Supervisory Board at the upcoming Annual General Meeting on June 11, 2026. This nomination aims to enhance Evotec's oversight and governance capabilities through additional industry, scientific, and governance expertise. Concurrently, Evotec entered into a cooperation agreement with MAK Capital Fund, a significant shareholder, following constructive discussions. This agreement includes customary voting and cooperation commitments, reflecting Evotec's dedication to shareholder engagement. The AGM agenda also includes the previously announced nomination of Dieter Weinand as Chairman of the Supervisory Board and a proposal to expand the Supervisory Board from six to seven members.

Entities Involved
per
Wolfgang Hofmann
Wolfgang Hofmann has been nominated for election as an independent member of Evotec's Supervisory Board, expected to contribute industry, scientific, and governance expertise.
Importance 80.0 Sentiment 10.0
priv
MAK Capital Fund
MAK Capital Fund, a key shareholder of Evotec, entered into a cooperation agreement with Evotec following constructive discussions, agreeing to voting and cooperation commitments.
Importance 70.0 Sentiment 5.0
per
Michael A. Kaufman
Michael A. Kaufman, CEO of MAK Capital Fund, welcomed Wolfgang Hofmann's nomination and expressed anticipation for continued collaboration with Evotec's boards.
Importance 30.0 Sentiment 0.0
per
Iris Löw-Friedrich
Iris Löw-Friedrich, Chairwoman of Evotec's Supervisory Board, expressed pleasure regarding Wolfgang Hofmann's nomination and the agreement with MAK Capital Fund.
Importance 30.0 Sentiment 0.0
per
Dieter Weinand
Dieter Weinand's nomination as Chairman of Evotec's Supervisory Board was previously announced and is part of the upcoming AGM agenda.
Importance 20.0 Sentiment 0.0
stock
Evotec
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.